Stem definition | Drug id | CAS RN |
---|---|---|
516 | 2622-30-2 |
None
None
Date | Agency | Company | Orphan |
---|---|---|---|
None | FDA | WYETH AYERST |
None
None
None
None
Source | Code | Description |
---|---|---|
CHEBI has role | CHEBI:37930 | phenothiazine antipsychotic drugs |
CHEBI has role | CHEBI:48561 | dopaminergic antagonists |
CHEBI has role | CHEBI:50919 | antiemetico |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Chronic schizophrenia | indication | 83746006 |
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 8.21 | Basic |
pKa2 | 4.21 | Basic |
pKa3 | 1.58 | Basic |
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
D(2) dopamine receptor | GPCR | ANTAGONIST | DRUGBANK | CHEMBL | |||||
5-hydroxytryptamine receptor 2A | GPCR | ANTAGONIST | CHEMBL | CHEMBL |
ID | Source |
---|---|
D02644 | KEGG_DRUG |
C0771221 | UMLSCUI |
CHEBI:51235 | CHEBI |
CHEMBL1201328 | ChEMBL_ID |
CHEMBL2358147 | ChEMBL_ID |
DB01038 | DRUGBANK_ID |
7140 | IUPHAR_LIGAND_ID |
2975-34-0 | SECONDARY_CAS_RN |
18104 | PUBCHEM_CID |
123579002 | SNOMEDCT_US |
782144003 | SNOMEDCT_US |
1179 | INN_ID |
CLY16Y8Z7E | UNII |
001486 | NDDF |
004593 | NDDF |
None